Vinaconex (VCG) Acquires 18% of Aegis Medical from CEO Family, Cuts 2026 Targets

Overview

Vinaconex (VCG) has approved a special transaction to acquire an 18% stake in Aegis Medical from the family of its CEO, Nguyễn Xuân Đông, for an estimated VND 180 billion. The move coincides with the company announcing significantly lower revenue and profit targets for 2026, alongside a planned share issuance to bolster financial capacity for future investments.

Key Facts

• Vinaconex will acquire 18 million shares, equivalent to 18% of the charter capital, in Aegis Medical.
• The sellers are CEO Nguyễn Xuân Đông (10 million shares), his wife Đỗ Thị Thanh (4.8 million shares), and his son Nguyễn Xuân Tùng (3.2 million shares).
• The transaction is valued at an estimated VND 180 billion, based on Aegis Medical’s charter capital of VND 1,000 billion as of September 2025.
• Aegis Medical is the investor behind the VND 4,500 billion Aegis International Healthcare Complex project, which Vinaconex commenced construction on in September 2025.
• For 2026, Vinaconex targets revenue of VND 15,423 billion and net profit of VND 1,037 billion, down 23% and 73% respectively from 2025 levels.
• The company plans to issue over 51.7 million shares to increase its charter capital to approximately VND 6,981 billion.
• The deal was approved via Resolution No. 02/2026 by Vinaconex’s Board of Directors.

What Happened

Vinaconex’s Board of Directors issued Resolution No. 02/2026, approving the acquisition of 18 million shares in Aegis Medical from three individuals: CEO Nguyễn Xuân Đông, his wife Đỗ Thị Thanh, and his son Nguyễn Xuân Tùng. This represents an 18% stake in Aegis Medical, with an estimated transaction value of VND 180 billion based on the company’s VND 1,000 billion charter capital as of September 2025. Aegis Medical is the developer of the VND 4,500 billion Aegis International Healthcare Complex, a project Vinaconex began constructing in September 2025.

In parallel, Vinaconex disclosed its 2026 business plan, targeting revenue of VND 15,423 billion and net profit of VND 1,037 billion. These figures represent a 23% decline in revenue and a 73% drop in profit compared to 2025 results. The company also announced intentions to issue more than 51.7 million shares to raise its charter capital to around VND 6,981 billion, aiming to strengthen financial resources for upcoming multi-sector investment activities.

Market Context

Vinaconex (VCG) trades on the HOSE exchange and closed at VND 22 on April 15, 2026, down 1.53% with a volume of 10,997,200 shares. The stock’s recent performance reflects broader market movements, but the announcement of reduced 2026 targets and a related-party transaction may influence investor sentiment. As a construction and materials sector player, Vinaconex’s pivot toward healthcare investments through this deal marks a strategic diversification effort.

Strategic Significance

The acquisition solidifies Vinaconex’s involvement in the Aegis healthcare project, potentially creating synergies between its construction expertise and the healthcare sector’s growth. However, the sharp reduction in 2026 profit targets suggests near-term operational challenges or a strategic shift in focus, possibly linked to capital allocation for new ventures like this stake purchase. The share issuance plan indicates a need for liquidity to fund these expansions, which could dilute existing shareholders but support long-term transformation.

What to Watch

• Completion of the VND 180 billion transaction for the 18% stake in Aegis Medical.
• Execution of the share issuance plan to raise capital to approximately VND 6,981 billion.
• Quarterly earnings reports in 2026 to assess progress toward the VND 15,423 billion revenue and VND 1,037 billion profit targets.
• Updates on the construction and development of the VND 4,500 billion Aegis International Healthcare Complex.
• Further disclosures on related-party transactions or investments within the An Quý Hưng ecosystem linked to CEO Nguyễn Xuân Đông.